Specialist Dr. Asela Gunawardena, the Director General of Health Services, has confirmed the release of the test report regarding the Immunoglobulin vaccine case. However, he stated that no statements can be made about the findings due to an ongoing court case related to the matter.
The testing of the vaccine took place in the quality control laboratory of the National Medicines Regulatory Authority and the laboratories of the Medical Research Institute. Dr. Gunawardena highlighted that the immunoglobulin testing occurred subsequent to the removal of the executive officer of the National Medicines Regulatory Authority, who was implicated in the alleged fraudulent transaction. The individual in question was subsequently appointed as the director of the Medical Research Institute.
During a press conference at the Ministry of Health, a journalist questioned Dr. Gunawardena regarding the timeline of the laboratory report’s release. The Director General clarified that the relevant laboratory report was released before the individual assumed the role of the director of the Medical Research Institute.
Dr. Gunawardena further mentioned that an internal investigation is underway concerning this transaction. He emphasized that the removal of a government official is a procedural matter that follows a proper program, and this process is currently being implemented.
